Charles B. Hicks

Initial B-Cell Responses to Transmitted Human Immunodeficiency Virus Type 1: Virion-Binding Immunoglobulin M (IgM) and IgG Antibodies Followed by Plasma Anti-gp41 Antibodies with Ineffective Control of Initial Viremia

Georgia D. Tomaras, Nicole L. Yates, Pinghuang Liu et al. · Journal of Virology · 2008 · 624 citations · Full text

Life Sciences, Immunology, Infectious Diseases +12

Heterogeneous neutralizing antibody and antibody-dependent cell cytotoxicity responses in HIV-1 elite controllers

Olivier Lambotte, Guido Ferrari, Christiane Moog et al. · AIDS · 2009 · 329 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17

Dolutegravir in Antiretroviral-Experienced Patients With Raltegravir- and/or Elvitegravir-Resistant HIV-1: 24-Week Results of the Phase III VIKING-3 Study

Antonella Castagna, Franco Maggiolo, Giovanni Penco et al. · The Journal of Infectious Diseases · 2014 · 329 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +16

Durable efficacy of tipranavir-ritonavir in combination with an optimised background regimen of antiretroviral drugs for treatment-experienced HIV-1-infected patients at 48 weeks in the Randomized Evaluation of Strategic Intervention in multi-drug reSistant patients with Tipranavir (RESIST) studies: an analysis of combined data from two randomised open-label trials

Charles B. Hicks, Pedro Cahn, David A. Cooper et al. · The Lancet · 2006 · 323 citations

Pharmacy, Pharmacology, Pharmacotherapy +15

High Multiplicity Infection by HIV-1 in Men Who Have Sex with Men

Hui Li, Katharine J. Bar, Shuyi Wang et al. · PLoS Pathogens · 2010 · 297 citations · Full text

Life Sciences, Evolutionary Biology, Infectious Diseases +11